PMV Pharmaceuticals, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:PMVP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 170.61 M152.85 M133.84 M116.56 M96.56 M Total liabilities 10.5 M12.25 M12.85 M11.85 M8.6 M Total equity 160.11 M140.6 M121 M104.71 M87.97 M Total liabilities & shareholders' equities 170.61 M152.85 M133.84 M116.56 M96.56 M Total debt ————— Net debt —————

News

PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why

PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

PMV Pharma’s rezatapopt study published in New England Journal

OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million

PMV Pharmaceuticals, Inc. (PMVP) Presents at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Slideshow (NASDAQ:PMVP) 2025-10-25

PMV Pharmaceuticals stock rises on positive cancer drug trial data

PMV Pharma to present initial data on TP53 mutation therapy at cancer conference

PMV Pharmaceuticals stock holds Buy rating at H.C. Wainwright on trial data

PMV Pharmaceuticals, Inc. (PMVP) Special Call - Slideshow (NASDAQ:PMVP)

PMV Pharmaceuticals stock rating reiterated at Buy by TD Cowen

Why Is PMV Pharmaceuticals Stock Falling Wednesday - PMV Pharma (NASDAQ:PMVP)

PMV Pharmaceuticals stock soars after promising cancer drug trial results